Next Post

US FDA Approves New Alzheimer's Drug - The St Kitts Nevis Observer

By Justine Coleman The Hill   The US Food and Drug Administration (FDA) on Monday granted approval for the first new Alzheimer’s treatment since 2003. The decision comes as the debate over whether to approve Biogen’s drug Aducanumab has stirred controversy, with some Alzheimer’s experts and an independent advisory committee […]